e-learning
resources
European Respiratory Review
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chitotriosidase: a marker and modulator of lung disease
De Chang, Lokesh Sharma, Charles S. Dela Cruz
Source:
Eur Respir Rev, 29 (156) 190143; 10.1183/16000617.0143-2019
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
De Chang, Lokesh Sharma, Charles S. Dela Cruz. Chitotriosidase: a marker and modulator of lung disease. Eur Respir Rev, 29 (156) 190143; 10.1183/16000617.0143-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Strong reversal of the lung fibrosis disease signature by autotaxin inhibitor GLPG1690 in a mouse model for IPF
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Hepatic function markers in COPD as a systemic implication of the disease
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008
Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
The value of adiponectin as an inflammatory marker in lung cancer?
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
alpha-v-beta-6 integrin may be a potential prognostic biomarker in interstitial lung disease
Source: Eur Respir J 2015; 46: 486-494
Year: 2015
Osteopontin and interleukin-6 as biomarkers of interstitial lung disease
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020
Red cell distribution width (RDW) as a biomarker of disease severity in ILD patients
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Serum neuron-specific enolase -
a marker for disease extent and response to therapy of small-cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 76s
Year: 2004
Hyaluronan: A novel sputum marker for the screening and diagnosis of lung cancer patients
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012
Comparative role of serum cathepsin S concentrations for differential diagnosis of sarcoidosis from other lung diseases
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
Serum napsin A is a novel diagnostic and monitoring marker for interstitial lung disease
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Telomerase activity as a prognostic marker in non small cell lung cancer
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008
Lipocalin-2: a biomarker potentially associated with predisposition to COPD
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Serum KL-6 as a biomarker to assess response to azathioprine in connective tissue disease associated lung disease (CTD-ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept